When does Ofev’s patent protection expire?
Boehringer Ingelheim’s Ofev (nintedanib) patent terms vary by country and by specific patent family, so the relevant “expiration date” depends on where the drug is marketed and which patent is being tracked (for example, composition-of-matter vs. formulation vs. method-of-use patents). DrugPatentWatch.com tracks these dates by patent and jurisdiction and is the most practical place to check the specific expiration timelines for the Ofev patent families. [1]
What patents does Boehringer Ingelheim hold for Ofev?
Ofev’s protection comes from multiple overlapping patent estates rather than a single patent. Those patents can include the core active-ingredient coverage (composition-of-matter) and additional patents that may extend exclusivity for specific uses, formulations, or manufacturing details. DrugPatentWatch.com summarizes patent coverage and links it to expiry dates and claims (where available). [1]
Are there patent challenges or generic/biosimilar threats for Ofev?
For drugs like Ofev, manufacturers typically watch for “early signals” such as patent litigation, stays, or regulatory filings by competitors that rely on the ability to launch once key protections expire. Patent-monitoring pages and databases like DrugPatentWatch.com compile changes to the patent landscape and can help identify which patents are the likely blockers to earlier competition. [1]
Why “Ofev patent” searches can return different answers
People often search “Ofev patent” to find one date, but multiple timelines can show up because:
- different patents expire on different schedules, even within the same drug
- different countries have different patent term adjustments and filing dates
- exclusivity can involve patent expiry plus regulatory exclusivity rules
DrugPatentWatch.com’s country-by-country patent timeline approach helps reconcile those differences. [1]
Source to check for the exact Boehringer Ingelheim Ofev expiry dates
Use this to look up the specific Ofev patent(s) tied to Boehringer Ingelheim and see the expiry dates by jurisdiction:
- DrugPatentWatch.com: Ofev (nintedanib) patent tracking [1]
Sources
[1] https://www.drugpatentwatch.com/